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INTRODUCTION
In response to acute infection, naive antigen-specific CD8+ 
T cells become activated, proliferate, and differentiate into 
a heterogeneous population of effector cells with the func-
tional capacity to eliminate the pathogen. Many effector 
CD8+ T cells within this population are thought to be ter-
minally fated to undergo apoptosis upon resolution of the 
infection. Others appear to be programmed for long-term 
survival and uniquely suited to protect the host upon rein-
fection (Chang et al., 2014). Considerable work in the field 
has focused on relating effector CD8+ T cell phenotype to 
cell fate. Two cell-surface receptors, killer cell lectin-like re-
ceptor G1 (KLRG1) and interleukin 7 receptor α (CD127), 
have been valuable in predicting the fates of CD8+ T cell 
populations at the peak of the effector response. During the 
effector phase of infection, CD8+ T cells expressing KLRG1 
and low levels of CD127, called terminal effector (TE) cells, 
are often defined as terminally differentiated, have a shorter 
life span and exhibit minimal memory potential in adoptive 
transfer experiments. CD8+ T cells with low KLRG1 and 
high CD127 surface expression in the effector phase have 
been defined as memory-precursor (MP) T cells and show a 
greater propensity to survive after infection and exhibit in-
creased stem-like properties such as self-renewal (Kaech et al., 
2003; Joshi et al., 2007; Sarkar et al., 2008).
At memory time points, the relationship of the canon-
ical markers, KLRG1 and CD127, to cell fate becomes less 
clear. Memory CD8+ T cells have been classified into subsets 
based on several criteria including location, effector function, 
capacity for self-renewal, and trafficking patterns. The best 
characterized distinction is that of effector memory (TEM) and 
central memory (TCM) T cells, based on CD62L and CCR7 
expression (Sallusto et al., 1999). TEM cells that lack CD62L 
and CCR7 expression circulate through nonlymphoid tissues 
and the blood and are poised to provide immediate effector 
function but have limited proliferation potential upon recall 
(Mueller et al., 2013). TCM cells express CD62L and CCR7 
and thus home to lymphoid tissues and provide a long-term, 
self-renewing pool of T cells (Mueller et al., 2013). Over-
laying the KLRG1 and CD127 phenotypic characterization 
of T cells adds a level of complexity to defining memory T 
cell subsets. Although CD127 expression supports long-term 
survival of memory T cells, the classification of TEM and TCM 
has not explicitly included the expression of CD127 or ex-
clusion of KLRG1. Within the TEM population, KLRG1 ex-
pression can be detected on a portion of cells (Masopust et 
al., 2006; Hikono et al., 2007; Phan et al., 2016; Kakaradov et 
al., 2017). This observation is consistent with TEM exhibiting 
more effector-like properties and being more terminally dif-
ferentiated (Kaech and Cui, 2012); however, variable KLRG1 
expression suggests the TEM population itself is heterogeneous. 
Furthermore, a sizeable population of CD8+ T cells defined as 
KLRG1hiCD127lo TE T cells at the effector stage survive after 
the infection has resolved and persist at memory time points, 
but the population continues to diminish relative to the KL-
RG1lo population, further supporting the idea that these cells 
are terminally fated (Olson et al., 2013).
Unique transcriptional programs have been described 
that drive the differentiation of CD8+ T cells during infec-
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tion—with T-bet, Blimp-1, IRF4, Zeb2, and Id2 acting as 
critical regulators of the TE CD8+ T cell population and Tcf1, 
Eomes, Bcl6, Foxo1, Id3, and E proteins regulating the MP 
CD8+ T cell population (Kaech et al., 2003; Joshi et al., 2007; 
Zhou et al., 2010; Chang et al., 2014). Although it is clear 
that these transcriptional regulators are key for the genera-
tion of effector and memory CD8+ T cell populations, lit-
tle is known about their roles in maintaining subset-specific 
gene-expression programs. When considering the transition 
of CD8+ effector T cells to memory populations, important 
questions arise: are effector CD8+ T cell populations uncon-
ditionally committed to their specified fate after infection 
resolution, or does plasticity exist and is active transcriptional 
regulation necessary to continually enforce subset specificity?
E-protein transcription factors (TFs) and their repres-
sors, Id (inhibitor of DNA binding) proteins, have emerged 
as key regulators of effector and memory CD8+ T cell differ-
entiation (Omilusik et al., 2013). E-protein activity increases 
upon T cell activation to induce a transcriptional network 
that promotes the formation of MP CD8+ T cells; and loss 
of E2A and HEB, two E-protein family members, results in 
increased frequencies of KLRG1hi effector CD8+ T cells after 
infection (D’Cruz et al., 2012). Id2 and Id3 are both thought 
to function by antagonizing E-protein activity, yet they differ-
entially impact the formation of CD8+ effector and memory 
T cell populations after acute infection (Cannarile et al., 2006; 
Ji et al., 2011; Yang et al., 2011; Knell et al., 2013; Masson 
et al., 2013). Loss of Id2 in naive CD8+ T cells results in an 
effector CD8+ T cell population that is highly susceptible to 
apoptosis with impaired survival after several bacterial or viral 
infections (Cannarile et al., 2006; Knell et al., 2016). Impor-
tantly, Id2-deficient CD8+ T cells fail to form the KLRG1hi 
TE subset and instead adopt an MP phenotype (Cannarile et 
al., 2006; Knell et al., 2013; Masson et al., 2013). Conversely, 
CD8+ T cells lacking Id3 have defects in formation and sur-
vival of long-lived memory (Ji et al., 2011; Yang et al., 2011). 
Here, we consider the transcriptional networks that actively 
maintain CD8+ T cell commitment and the acquired pheno-
typic and functional subset-specific properties. In particular, 
we examine the role of Id2 and E-proteins in enforcing the 
TE CD8+ T cell fate after resolution of infection. We find 
that memory T cell fates are more plastic than anticipated and 
that sustained regulation of E-protein activity is necessary to 
maintain the effector or TE CD8+ T cell phenotype.
RESULTS AND DISCUSSION
Id2 is expressed in CD8+ T cells throughout the effector and 
into the memory phase after infection (Fig. S1 A; Cannarile et 
al., 2006). Id2 promotes survival and terminal differentiation 
of CD8+ T cells at the peak of several acute infections (Can-
narile et al., 2006; Knell et al., 2013; Fig. S1, B–H). Effector 
and TE CD8+ T cells deficient for Id2 fail to accumulate after 
infection, and the lack of CD8+ T cells makes it difficult to at-
tribute a functional role for Id2 in homeostasis of T cell pop-
ulations at later time points. To circumvent this, we crossed 
mice with loxP-flanked Id2 alleles (Id2f/f; Niola et al., 2012) to 
Rosa26Cre-ERT2 mice (ERCre) to allow inducible deletion 
of Id2 upon tamoxifen treatment. These mice were further 
mated with P14 transgenic mice that express an H-2Db– 
restricted T cell antigen-receptor specific for lymphocytic 
choriomeningitis virus (LCMV) glycoprotein33–41. Treatment 
of naive Id2f/f-ERCre+ P14 mice with tamoxifen induced a 
near complete deletion of Id2 in CD8+ T cells when com-
pared with Id2f/f-ERCre− P14 T cells that had been similarly 
treated (Fig. S1, B and C; mice called Id2WT or Id2KO after 
induced Id2 deletion with tamoxifen). Upon mixed transfer 
of P14 T cells into congenically distinct hosts, CD8+ T cells 
with induced deletion of Id2 responding to LCMV infec-
tion had an accumulation and differentiation defect on day 8 
of infection compared with Id2WT CD8+ T cells consistent 
with our previously published results studying CD8+ T cells 
with germline Id2 deficiency after infection (Fig. S1, D and 
E; Cannarile et al., 2006; Knell et al., 2013). Further, when 
deletion was induced at the peak of infection (5–10 d), the 
Id2-deleted effector and TE CD8+ T cells rapidly declined 
within days compared with the Id2WT cells (Fig. S1, F–H).
Having developed an efficient model in which to in-
duce deletion of Id2, we sought to assess the role of Id2 in 
established memory CD8+ T cells. Untreated Id2f/f-ERCre+ 
and Id2f/f-ERCre− P14 CD8+ T cells were co-transferred 
at a 1:1 ratio into congenically distinct recipient mice 1 d 
before LCMV infection. After day 30 of infection, recipient 
mice were treated with tamoxifen to induce deletion of Id2 
(Fig. 1 A; and Fig. S1, I and J). After tamoxifen treatment (15–
16 d), Id2WT and Id2KO CD8+ T cells persisted in the blood, 
spleen, and lymph nodes (LNs) of the host at equivalent fre-
quencies and numbers (Fig. 1, B and C; and Fig. S1 K). Strik-
ingly, in this short duration of Id2 deficiency, the phenotype 
of the Id2KO CD8+ T cell population significantly changed 
compared with that of the Id2WT cells. Most prominently in 
the blood and spleen, the shorter-lived, more effector-like KL-
RG1hiCD127lo and KLRG1hiCD127hi Id2KO CD8+ T cell 
subsets almost completely disappeared, whereas the frequency 
of the more long-lived KLRG1loCD127hi Id2KO CD8+ T 
cells significantly increased (Fig. 1, B and D; Joshi et al., 2007; 
Sarkar et al., 2008). No differences in Ki67 were observed, 
indicating that the phenotypic changes occurred in the ab-
sence of proliferation (not depicted). Consistent with a con-
version by the effector-like cells, the CD27loCD43lo CD8+ T 
cell population, a subset of long-lived effector T cells (Olson 
et al., 2013), was also lost upon Id2 deletion, whereas a pro-
portional increase in the CD27hiCD43lo/hi CD8+ T cells was 
observed when compared with the Id2WT controls (Fig. 1, B 
and D). Furthermore, when analyzing the CD8+ T cells from 
the blood and spleen based on CD62L, a marker classically 
used to define circulating memory CD8+ T cells or TCM cells 
(Sallusto et al., 1999), we found that the frequency of the 
CD62LloCD127lo long-lived effector Id2KO CD8+ T cells 
declined compared with Id2WT CD8+ T cells. (Fig. 1, E and 
F). The loss of cells with a KLRG1hi phenotype in the Id2KO 
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CD8+ T cell population was accompanied by increased ex-
pression of memory-associated TFs, Tcf1 and Foxo1 (Zhou 
et al., 2010; Hess Michelini et al., 2013), and a decrease in the 
effector-associated protein, T-bet (Joshi et al., 2007; Fig. 1 G). 
There were not significant differences in CD122 or CD127 
levels for the Id2-deficient cells that had converted to a KLR-
G1lo phenotype compared with WT cells, indicating a similar 
potential for cytokine responsiveness (not depicted). We did 
note that at >20 d after induced Id2 deletion, the ratio of 
Id2KO to Id2WT donor cells began to fall, indicating that 
Id2 deficiency did eventually impair survival, in addition to 
profoundly affecting phenotype at earlier time points (Fig. S1 
K). These results suggest that the effector differentiation state 
may be more actively controlled than previously appreciated 
and that continual Id2 transcriptional regulation is required 
to maintain the KLRG1hi effector/effector-memory CD8+ 
T cell differentiation.
The maintenance of Id2WT and Id2KO CD8+ T cells 
in a 1:1 ratio after Id2 deletion at early time points indicates 
that, in the absence of regulation of E-protein activity, effec-
tor-like Id2KO CD8+ T cells that have been presumed to 
be terminally fated dedifferentiate to resemble the long-lived 
KLRG1loCD127hiCD27hi T cell population. To understand if 
the loss of day 30 KLRG1hi effector/effector-memory Id2KO 
CD8+ T cells was due to altered cell fates, cell death, or in-
creased KLRG1lo cell proliferation, we sorted, transferred, and 
induced Id2 deletion in CD8+ T cell subsets and followed 
them over time (Fig. 2 A). Untreated Id2f/f-ERCre+ and Id2f/f- 
ERCre− P14 CD8+ T cells were co-transferred into congen-
ically distinct recipient mice that were infected the next day 
with LCMV. After day 30 of infection, KLRG1hiCD127lo 
and KLRG1loCD127hi P14 CD8+ T cells subsets that were 
Id2f/f-ERCre+ or Id2f/f-ERCre− were sorted from the spleen 
and LN of recipient mice. KLRG1hiCD127lo Id2f/f-ERCre+ 
and Id2f/f-ERCre− (KLRG1hi transfer) or KLRG1loCD127hi 
Id2f/f-ERCre+ and Id2f/f-ERCre− (KLRG1lo transfer) were 
mixed at a 1:1 ratio and transferred to new congenically 
distinct recipient mice, which were subsequently treated 
with tamoxifen to induce Id2 deletion (Fig. S2, A and B). 
The frequency and number of Id2WT and Id2KO CD8+ 
T cells in the spleens of recipient mice receiving the 
KLRG1hi CD8+ T cell transfer was not affected on day 6 
or 32 after tamoxifen treatment (Fig. 2, B and C). However, 
by day 32, the proportion and number of Id2KO CD8+ T 
cells from the KLRG1lo transfer were significantly reduced 
compared with the Id2WT CD8+ T cells. The phenotype of 
the transferred KLRG1lo CD8+ T cells remained KLRG1lo 
CD127hi and CD27hi after Id2 deletion, whereas the KLRG1hi 
Id2KO CD8+ T cells significantly down-regulated KLRG1 
and up-regulated CD27, resembling a more long-lived T 
cell population (Fig.  2, B and D). The Id2WT cells in the 
KLRG1hi transfer partially up-regulated CD127, albeit not 
to the degree as the Id2KO CD8+ T cells, likely to support 
the long-term survival of the transferred cells. Notably, there 
is an increase in CD62L expression among KLRG1hi trans-
ferred cells after Id2 deletion (Fig. 2, E and F). The Id2KO 
KLRG1hi CD8+ T cells also significantly up-regulated Tcf1 
expression and down-regulated T-bet expression consis-
tent with reassignment from an effector-like phenotype to a 
memory-like phenotype (Fig. 2 G). The KLRG1lo transferred 
cells lost Eomes expression after Id2 deletion (Figs. 1 G and 
2 F), suggesting that Id2 differentially affects the CD8+ T cell 
populations consistent with multiple roles—promoting sur-
vival in the KLRG1loCD127hi CD8+ T cells and enforcing 
differentiation in the KLRG1hiCD127lo CD8+ T cells. These 
results imply that differentiation to a KLRG1hi effector CD8+ 
T cell subset is a reversible process and that sustained Id2 
regulation enforces the cell state of “terminal differentiation.”
The loss of Id2 in long-lived KLRG1hi effector CD8+ 
T cells leaves them phenotypically resembling CD8+ T cells 
with more memory potential, so we sought to test their abil-
ity to recall after reinfection. After day 30 of LCMV infec-
tion, untreated KLRG1hiCD127lo and KLRG1loCD127hi 
Id2f/f-ERCre+ and Id2f/f-ERCre− P14 CD8+ T cells were 
sorted and co-transferred as above (Fig. 2 A), and 6 d after 
tamoxifen treatment to induce Id2 deletion, the host mice 
were rechallenged with LCMV. Following the kinetics of the 
CD8+ T cell response in the blood, we found that the Id2KO 
CD8+ T cells of the KLRG1hi transferred cells, which had 
largely lost KLRG1 expression, peaked 1 d sooner than the 
equivalent Id2WT CD8+ T cells after infection (Fig. 3 A). As 
previously observed in primary responses (Cannarile et al., 
2006; Knell et al., 2013; Fig. S1), the CD8+ T cells deficient for 
Id2 failed to accumulate in the late effector stage of the sec-
ondary response, and after day 7 of reinfection the proportion 
of Id2KO CD8+ T cells of both the KLRG1hi and KLRG1lo 
transfer was largely diminished compared with the Id2WT 
CD8+ T cells. We examined the phenotype of the responding 
Id2WT and Id2KO CD8+ T cells in the spleen of recipients at 
day 9 after infection (Fig. 3, B–D). Although the Id2KO CD8+ 
T cells of the KLRG1lo transfer were significantly impaired 
in their ability to differentiate into KLRG1hiCD127lo effector 
cells much like in a primary response (Cannarile et al., 2006; 
Knell et al., 2013; Masson et al., 2013; Fig. S1), ∼60% of the 
Id2KO CD8+ T cells of the KLRG1hi transfer, despite being 
largely KLRG1lo at the time of rechallenge (Fig.  2, B and 
D), were able to re-express KLRG1. Yet, the Id2KO CD8+ T 
cells remained primarily CD27hi with increased expression 
of Tcf1 and Foxo1 and lower levels of T-bet compared with 
Id2WT CD8+ T cells (Fig. 3, C and D; and Fig. S2 C). The 
Id2KO CD8+ T cells likely persisted at a lower frequency 
at the late effector stage of rechallenge because of impaired 
survival demonstrated by reduced BCL2 (Fig. S2 C). Thus, 
KLRG1hi cells with induced Id2 deletion responded more 
rapidly to reinfection than their WT counterparts, showing 
characteristics consistent with a memory phenotype.
To more thoroughly understand how Id2 affects the 
gene-expression profile of established KLRG1hi effector/ef-
fector-memory CD8+ T cell populations, we studied global 
transcriptional changes in CD8+ T cells that resulted from 
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induced deletion of Id2. On day 26 of LCMV infection, 
KLRG1hiCD127lo and KLRG1loCD127hi Id2f/f-ERCre+ 
and Id2f/f-ERCre− P14 CD8+ T cells were sorted and 
co-transferred as in Fig. 2 A, and 6 d after tamoxifen treat-
ment Id2WT and Id2KO T cell populations were sorted for 
RNA sequencing (RNA-Seq) analysis. Differential expres-
sion of genes associated with KLRG1hiCD127lo or KLRG1lo 
CD127hi CD8+ T cell populations from 30 or more days of 
infection was confirmed by comparison of Id2WT CD8+ 
T cells from the KLRG1hi or KLRG1lo transfers (Fig. 4 A, 
Figure 1. Late deletion of Id2 in antigen-specific CD8+ T cells results in conversion from a KLRG1hi to KLRG1lo population. (A) Schematic of ex-
perimental set-up. CD45.1 hosts were given a cotransfer of Id2f/f-ERCre− (CD45.1.2) and Id2f/f-ERCre+ (CD45.2) P14 CD8+ T cells then subsequently infected 
with LCMV. More than 30 d after infection, host mice were treated for 5 consecutive days with tamoxifen (Tam) to induce Id2 deletion. Id2f/f-ERCre− and Id-
2f/f-ERCre+ CD8+ T cells are called Id2WT or Id2KO, respectively, after Tam treatment. (B) Flow cytometry of transferred P14 CD8+ T cells from host peripheral 
blood lymphocytes (PBL) or spleen (Sp) and LN 15 or 16 d after the last Tam treatment, respectively. Frequency of Id2WT and Id2KO cells among P14 CD8+ 
T cells (left), KLRG1 and CD127 expression (middle), and CD27 and CD43 expression (right) are shown. Numbers in plots represent the percentage of cells. 
(C) Quantification of donor cell frequency and number or (D) frequency of populations from B. (E) Flow cytometry of cells from B for CD62L and CD127 
expression. (F) Quantification of donor populations from E. (G) Expression of indicated proteins on KLRG1hi or KLRG1lo Id2WT or Id2KO donor populations. 
Data shown are representative of three (B and D–F) independent or cumulative of two or three (C and G) independent experiments; n = 3–5 mice per group. 
Data are expressed as mean ± SEM. *, P < 0.05; **, P < 0.01; ***, P < 0.001 (two-tailed paired Student’s t test).
777JEM Vol. 215, No. 3
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left). We compared gene expression between the Id2WT 
and Id2KO CD8+ T cells from the KLRG1hi transfer and 
found that Id2KO KLRG1hi CD8+ T cells, in addition to 
down-regulating KLRG1 and T-bet protein expression, 
down-regulated mRNA of effector-associated genes (Prdm1, 
Tbx21, Zeb2, and Gzmb) and up-regulated mRNA of mem-
ory-associated genes (Id3, Ccr7, and Tcf7) upon Id2 deletion 
(Fig.  4  A, right). Principal component analysis confirmed 
that the induced deletion of Id2 resulted in the Id2KO KL-
RG1hi CD8+ T cells rapidly adopting a transcriptional profile 
that was distinct from WT KLRG1hi CD8+ T cells and more 
closely resembling MP or memory (TEM, TCM) cells (Fig. 4 B).
To more carefully characterize the effect of induced 
Id2 deletion on genes that are effector or memory associated, 
we compared expression of genes differentially expressed be-
tween Id2WT and Id2KO CD8+ T cells from the KLRG1hi 
transfer to TE and MP gene signatures and TEM and TCM gene 
signatures previously established in our laboratory (Milner et 
al., 2017; Yu et al., 2017). It should be noted that TEM and 
TCM populations were isolated by sorting on the CD62Llo 
or CD62Lhi P14 CD8+ T cell populations and did not ex-
clude KLRG1 to be consistent with other studies (Chang et 
al., 2014); therefore, it is likely that long-lived TE may be a 
component of our TEM signature. Id2KO CD8+ T cells lost 
expression of 79% of the TE signature genes and up-regulated 
expression of 69% of the MP-associated genes compared with 
the Id2WT CD8+ T cells (Fig. 4 C, top; P < 0.001). Similarly, 
Id2KO CD8+ T cells lost expression of 83% or up-regulated 
expression of 88% of TEM or TCM signature genes, respectively 
(Fig. 4 C, bottom; P < 0.001). These analyses indicate a sub-
stantial skewing away from an effector-like and toward a TCM 
CD8+ T cell transcriptional program by the so-called “termi-
nally differentiated” KLRG1hiCD127lo Id2KO CD8+ T cells, 
rapidly following induction of Id2 deletion.
The dedifferentiation of long-lived KLRG1hi CD8+ T 
cells to memory-like KLRG1loCD127hi CD8+ T cells in the 
absence of continual Id2 regulation suggests that restrained 
E-protein activity is necessary to maintain a KLRG1hi effec-
tor CD8+ T cell phenotype. To confirm that E-protein ac-
tivity, the presumed target of Id2, determines and maintains 
the fate of CD8+ T cells after infection, we analyzed genes 
differentially expressed between Id2WT or Id2KO KLRG1hi 
CD8+ T cells that are identified E2A targets (Leong et al., 
2016) and are defined in the TE and MP or TEM and TCM 
gene signatures (Fig. 4 D). We found a substantial number of 
E2A-bound genes that were differentially up-regulated (Id3, 
Ccr7, Tcf7, and Cd27) and down-regulated (Prdm1, Ccl3, 
and Gzma) upon induced deletion of Id2. This suggests that 
Id2 mediation of E-protein activity plays a key role in enforc-
ing effector CD8+ T cell terminal differentiation. It then fol-
lows that diminished levels of E2A would “rescue” the effector 
CD8+ T cell dedifferentiation observed in Id2-deficient cells. 
Therefore, we transduced Id2f/f-ERCre+ and Id2f/f-ERCre− 
P14 CD8+ T cells with a retroviral shRNA vector targeting 
the gene encoding E2A (shTcf3) or control shRNA (shCd19; 
Fig. 4 E and Fig. S3 A) as previously described (Shaw et al., 
2016). Id2f/f-ERCre+ and Id2f/f-ERCre− P14 CD8+ T cells 
transduced with shTcf3 or shCd19 were mixed in a 1:1 ratio 
and co-transferred to congenically distinct recipients that had 
been infected 1 d earlier with LCMV. On day 15 of infec-
tion, recipient mice were treated with tamoxifen to induce 
deletion of Id2, and the phenotype of the transferred CD8+ 
T cells in recipient spleens was analyzed. As expected, the 
Id2KO CD8+ T cells expressing control shCd19 were un-
able to maintain a differentiated population of CD8+ T cells 
defined as KLRG1hiCD127lo and CD27loCD43lo. However, 
the Id2KO CD8+ T cells with diminished expression of Tcf3 
were almost completely rescued with the frequency of KL-
RG1hiCD127lo and CD27loCD43lo populations nearly equiv-
alent to Id2WT CD8+ T cell population (Fig. 4, F and G). 
Therefore, the loss of the effector-like CD8+ T cell popula-
tion we observed upon Id2 deletion can be attributed largely 
to increased E-protein activity.
Loss of Id2 and enhanced E-protein activity dispro-
portionally impact the KLRG1hi effector-like CD8+ T cell 
population at memory time points with a rapid and dramatic 
shift in phenotype and overall gene expression of KLRG1hi 
CD8+ T cells to a memory-like state, whereas the KLRG1lo 
CD8+ T cells showed moderately lower Eomes expression 
and impaired survival at later time points (by day 32). Al-
Figure 2. Id2 is necessary to maintain the terminal differentiation of antigen-specific CD8+ T cells. (A) Schematic of experimental set-up. CD45.1 
hosts were given a cotransfer of Id2f/f-ERCre− (CD45.1.2) and Id2f/f-ERCre+ (CD45.2) P14 CD8+ T cells and then subsequently infected with LCMV. At >30 
d after infection, KLRG1hiCD127lo and KLRG1loCD127hi, Id2f/f-ERCre−, and Id2f/f-ERCre+ P14 CD8+ T cells were sort purified. Id2f/f-ERCre− and Id2f/f-ERCre+ 
KLRG1hiCD127lo (KLRG1hi transfer) or Id2f/f-ERCre− and Id2f/f-ERCre+ KLRG1loCD127hi (KLRG1lo transfer) populations were co-transferred into naive CD45.1 
hosts that were treated with tamoxifen (Tam). Id2f/f-ERCre− and Id2f/f-ERCre+ CD8+ T cells are called Id2WT or Id2KO, respectively, after Tam treatment. (B) 
Flow cytometry of transferred P14 CD8+ T cells from host spleen 6 d (top) or 32 d (bottom) after last Tam treatment. Frequency of Id2WT and Id2KO cells 
among P14 CD8+ T cells (left), KLRG1 and CD127 expression (middle), and CD27 and CD43 expression (right) for the KLRG1hi and KLRG1lo transfer are shown. 
Numbers in plots represent the frequency of cells in that quadrant. (C) Quantification of donor cell frequency and number from KLRG1hi (Hi) or KLRG1lo 
(Lo) transfers from B. (D) Quantification of donor populations from KLRG1hi (left) and KLRG1lo (right) transfer. (E) Flow cytometry of transferred P14 CD8+ 
T cells from host spleen 6 d after last Tam treatment. CD62L and CD127 expression for the KLRG1hi and KLRG1lo transfers is shown. (F) Quantification of 
donor populations from E. (G) Expression of indicated transcription factors on KLRG1hi or KLRG1lo Id2WT or Id2KO donor populations from hosts receiving 
KLRG1hi transferred (left) and KLRG1lo transferred (right) cells 6 d after last Tam treatment. Data shown are representative (B, E, and G) or cumulative (C, 
D, and F) of two independent experiments; n = 3–4 mice per group. Data are expressed as mean ± SEM. *, P < 0.05; **, P < 0.01; ***, P < 0.001 (two-tailed 
paired Student’s t test).
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though we noted a 1.9-fold increase in mRNA expression of 
Id2 in the KLRG1hiCD127lo compared with the KLRG1lo 
CD127hi CD8+ T cells (Fig.  4  A, left) and higher Id2 re-
porter expression has been observed in TEM cells versus TCM 
cells after influenza infection (Masson et al., 2013), we did 
not detect differential Id2 reporter levels between KLRG1hi 
CD127lo and KLRG1loCD127hi CD8+ T cells or Id2 protein 
levels between TEM and TCM in our experiments (Fig. S3 B). 
This suggests that the increased dependency on Id2 observed 
in the KLRG1hi compared with KLRG1lo CD8+ T cells was 
not due to substantially differing expression levels. Using 
the assay for transposase-accessible chromatin–sequencing 
(ATAC-Seq) data for naive, TE, and MP or TCM and TEM 
CD8+ T cells assessed 0, 7, 30, or 180 d after LCMV infection, 
we analyzed chromatin accessibility of MP or TCM E-protein 
target genes that were differentially regulated upon Id2 dele-
tion (Fig. 4 D). E-protein binding sites in Tcf7, Cd27, Cxcr5, 
Ccr7, and Id3, identified by using E2A chromatin immu-
noprecipitation–sequencing (ChIP-Seq; Leong et al., 2016), 
were accessible in the naive, TE, MP, TCM, and TEM popula-
tions analyzed (Fig. S3 C and not depicted). This suggests 
that other factors contribute to CD8+ T cell subset-specific 
E-protein regulation. For example, Zeb2, a transcription fac-
tor highly expressed in TE and TEM CD8+ T cells and found 
to be important for terminal differentiation (Dominguez 
et al., 2015; Omilusik et al., 2015; Kakaradov et al., 2017), 
can bind DNA at tandem, separated E-protein binding sites 
(Sekido et al., 1994; Remacle et al., 1999). We identified such 
a site within the Tcf7 gene (Fig. S3 C), suggesting Zeb2 may 
function in KLRG1hi effector-like CD8+ T cell populations 
Figure 3. Deletion of Id2 in KLRG1hi memory CD8+ T cells results in the faster initiation of a recall response. Id2f/f-ERCre− and Id2f/f-ERCre+ 
KLRG1hi or KLRG1lo P14 CD8+ T cells were co-transferred into naive CD45.1 hosts, and Id2 deletion was induced as described in Fig. 2 A. Host mice were 
infected with LCMV 7 d after the last tamoxifen treatment. Id2f/f-ERCre− and Id2f/f-ERCre+ CD8+ T cells are called Id2WT or Id2KO, respectively, following 
tamoxifen treatment. (A) The frequency of total Id2WT and Id2KO P14 donor cells (top) or Id2WT and Id2KO P14 cells of total CD8+ T cells (bottom) in PBL on 
indicated days after infection is shown. (B) Flow cytometry (left) and quantification (right) of the frequency of Id2WT and Id2KO P14 CD8+ T cells from host 
spleen 9 d after infection for KLRG1hi and KLRG1lo transfers. (C) Flow cytometry of KLRG1 and CD127 expression (left) and CD27 and CD43 expression (right) 
for KLRG1hi and KLRG1lo transfers are shown. (D) Quantification of donor populations from C after KLRG1hi (top) and KLRG1lo (bottom) transfer. Numbers 
in plots represent the percentage of cells. Data shown are cumulative (total donor frequency; A, top) or representative (total CD8+ population frequency; 
A, bottom), representative (B), or cumulative (C) of two independent experiments; n = 2–4 mice per group. Data are expressed as mean ± SEM. *, P ≤ 0.05; 
**, P < 0.01; ***, P < 0.001 (one-tailed paired [A and B] or two-tailed paired [D] Student’s t test).
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Figure 4. Id2 regulation of E2A binding regulates expression of key effector CD8+ T cell genes. (A–D) Id2f/f-ERCre− (CD45.1.2) and Id2f/f-ERCre+ 
(CD45.2) KLRG1hi or KLRG1lo P14 CD8+ T cells were co-transferred into naive CD45.1 hosts, and Id2 deletion was induced as described in Fig.  2  A. 
Id2f/f-ERCre− and Id2f/f-ERCre+ CD8+ T cells are called Id2WT or Id2KO, respectively, after tamoxifen (Tam) treatment. On day 6 after the last Tam treatment, 
Id2WT and Id2KO cells were sorted for RNA-Seq. (A) Gene expression by cells from the Id2WT KLRG1hi transfer versus Id2WT KLRG1lo transfer (left) or from 
the Id2WT KLRG1hi transfer versus Id2KO KLRG1hi transfer (right) for genes differentially expressed by 1.5-fold or more, a coefficient of variation of ≤0.50, 
and an expression value of ≥10; colors indicate genes up-regulated 1.5-fold or more in the cells from the Id2WT KLRG1hi transfer relative to their expression 
in cells from the Id2WT KLRG1lo transfer (green) or vice versa (purple), or genes up-regulated in cells from the Id2WT KLRG1hi transfer relative to cells from 
the Id2KO KLRG1hi transfer (green) or vice versa (magenta). Labels in plots indicate genes of published relevance to CD8+ T cell differentiation and memory 
formation. (B) Principal component analysis of gene expression in Id2WT and Id2KO P14 CD8+ T cells from the KLRG1hi and KLRG1lo transfers, in TE and MP 
P14 CD8+ T cell populations at day 7 of LCMV infection, and in TCM, and TEM P14 CD8+ T cell populations at day 180 of LCMV infection. (C) Expression of TE- or 
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to repress E-protein activity and thus the memory-gene ex-
pression program. Perhaps enhanced E-protein activity upon 
the loss of Id2 expression may outcompete Zeb2 for E-box 
sites, resulting in greater expression of Tcf7, which then could 
promote the TCM, long-lived memory phenotype.
Ultimately these results show that the concept of ter-
minal differentiation may be flawed in the context of CD8+ 
memory T cell differentiation. KLRG1 may not be a defin-
itive marker of terminal differentiation, and bona fide, ter-
minally differentiated CD8+ T cells may die shortly after 
resolution of the infection, leaving a less-differentiated 
KLRG1hi population that persists at memory time points. In-
stead, we support the notion that CD8+ T cell differentiation 
is flexible and sustained inhibition of E-protein activity by 
Id2 allows the survival of an effector-like population that can 
reacquire at least a portion of the TCM, or long-lived mem-
ory gene-expression program, favoring the idea of plasticity 
of cell states over fixed cell fates among the heterogeneous, 
post-infection CD8+ T cell population.
MATERIALS AND METHODS
Mice
All mouse strains were bred and housed in specific patho-
gen–free conditions in accordance with the Institutional An-
imal Care and Use Guidelines of the University of California 
San Diego. Id2-YFP mice (Yang et al., 2011), Id2fl/fl mice 
(Niola et al., 2012), Rosa26Cre-ERT2 (ERCre) mice (Hess 
Michelini et al., 2013), P14 mice (with transgenic expression 
of H-2Db–restricted TCR specific for LCMV glycoprotein 
gp33), and CD45.1 and CD45.1.2 congenic mice were bred 
to obtain a fully C57BL/6J background. Both male and fe-
male mice were used throughout the study, with sex- and 
age-matched T cell donors and recipients.
Cell transfer, LCMV infection, and tamoxifen treatment
Congenically distinct Id2f/f-ERCre− and Id2f/f-ERCre+ P14 
CD8+ T cells were mixed at a 1:1 ratio and adoptively trans-
ferred at 5 × 104 cells per CD45.1 recipient mouse. Mice 
were then infected with 2 × 105 PFU LCMV-Armstrong by 
intraperitoneal injection. At day 5 or >30 d after infection, 
Rosa26Cre-ERT2-mediated deletion of floxed alleles was 
induced by intraperitoneal injection for 5 consecutive days 
of 1 mg tamoxifen (Cayman Chemical Company) emulsified 
in 100 ml sunflower seed oil (Sigma-Aldrich). Alternatively, 
>30 d (or at 26 d for RNA-Seq analysis) after infection, KL-
RG1hiCD127lo and KLRG1loCD127hi populations from total 
P14 CD8+ T cells were sorted from recipient spleen and LN, 
mixed in a 1:1 ratio of KLRG1hiCD127lo Id2f/f- ERCre+/
Id2f/f-ERCre− or KLRG1loCD127hi Id2f/f- ERCre+/Id2f/f- 
ERCre− and then transferred at 1.5 × 105 total cells per 
CD45.1 recipient mouse. The next day, tamoxifen was admin-
istered as above for five consecutive days to induce Id2 dele-
tion. At 6 or 32 d after the last tamoxifen treatment, Id2WT 
and Id2KO populations were assessed by flow cytometry or 
sorted for RNA-Seq (as described in the RNA-Seq section), 
or recipients were rechallenged intraperitoneally with 2 × 
105 PFU LCMV-Armstrong.
RT-PCR and qPCR
To confirm Id2 deletion or Tcf3 knockdown, total RNA 
was extracted by using Trizol (Life Technologies) from sorted 
Id2WT and Id2KO P14 CD8+ T cells. cDNA was synthe-
sized by using Superscript II kit (Life Technologies) follow-
ing the manufacturer's instructions. For qPCR, cDNA was 
quantitatively amplified by using Stratagene Brilliant II Syber 
Green master mix (Agilent Technologies). The abundance 
of transcripts was normalized to that of the housekeeping 
gene Hprt. The following primers were used: Id2 forward, 
5′-TCC CTT CTG AGC TTA TGT CG-3′ and Id2 reverse, 
5′-GTC CAT TCA ACG TGT TCT CC-3′; Tcf3 forward, 5′-
CAT CCA TGT CCT GCG AAG CCA-3′ and Tcf3 reverse, 
5′-TTC TTG TCC TCT TCG GCGT-3′; Hprt forward, 5′-
GGC CAG ACT TTG TTG GAT TT-3′, and Hprt reverse: 5′-
CAA CTT GCG CTC ATC TTA GG-3′.
Flow cytometry and cell sorting
Single-cell suspensions were prepared from spleen, LN, or 
blood. The following antibodies were used for surface stain-
ing (all from eBioscience): CD8 (53-6.7), CD27 (LG-7F9), 
CD43 (1B11), CD45.1 (A20-1.7), CD45.2 (104), CD62L 
(MEL-14), CD122 (TM-b1), CD127 (A7R34), CXCR3 
(CXCR3-173), and KLRG1 (2F1). Cells were incubated for 
30 min at 4°C in PBS supplemented with 2% bovine growth 
serum and 0.1% sodium azide. Intracellular staining was per-
formed by using the Foxp3 Transcription Factor Staining 
Buffer kit (eBioscience) and the following antibodies (all 
from eBioscience unless otherwise specified): BCL2 (3F11; 
BD PharMingen), Eomes (Dan11mag), Foxo1 (C29H4; Cell 
Signaling), Gzmb (GB12; Invitrogen), Id2 (ILC ID2; Thermo 
Fisher Scientific), Tbet (eBio4B10), and Tcf1 (C63D9; Cell 
MP-associated genes (top) or TEM- or TCM-associated genes (bottom) assessed in cells from the Id2KO KLRG1hi transfer versus cells from the Id2WT KLRG1hi 
transfer and plotted against p-value. Numbers in the corners indicate the total of those genes up-regulated in cells from the Id2KO KLRG1hi transfer (top 
left) or from the Id2WT KLRG1hi transfer (top right). P < 0.001 (χ2 test). (D) Relative expression of TE and MP genes (top) and TEM and TCM genes (bottom) 
from C that are putative E2A-target genes identified by ChIP-Seq (bar colors match dot colors in C). (E) Schematic of experimental set-up. CD45.1 host 
mice infected 1 d before received a cotransfer of Id2f/f-ERCre− and Id2f/f-ERCre+ P14 CD8+ T cells transduced with control shRNA targeting Cd19 or with 
shTcf3. At 15 d of infection, host mice were treated with tamoxifen (Tam) to induce Id2 deletion. (F) Flow cytometry of transferred cells 9 d after the last 
Tam treatment for KLRG1 and CD127 expression (left) and CD27 and CD43 expression (right). Numbers in the plots represent the percentage of cells. (G) 
Quantification of donor populations from highlighted populations in F. Data are representative of two (A–D) or three (F) and cumulative of three (G) inde-
pendent experiments; n = 3–5 mice per group. Data are expressed as mean ± SEM. **, P < 0.01 (two-tailed paired Student’s t test).
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Signaling). Stained cells were analyzed by using LSRFortessa 
or LSRFortessa X-20 (BD) and FlowJo software (Tree-
Star). All sorting was performed on BD FAC SAria or BD 
FAC SAria Fusion instruments.
shRNA-mediated knockdown by retroviral transduction
DNA fragments encoding shRNA targeting mouse Tcf3 or 
Cd19 were subcloned into a custom retroviral vector con-
taining ametrine as a reporter. Naive congenically distinct 
Id2f/f-ERcre+ and Id2f/f-ERcre− P14 CD8+ T cells were stim-
ulated for 18 h in 6-well plates precoated with anti-CD3 and 
anti-CD28. After stimulation, cells were transduced by adding 
retroviral supernatants supplemented with 100 U/ml human 
IL-2 and 8 µg/ml polybrene, followed by centrifugation for 
90 min at 2000 g at 37°C. After transduction, cells were in-
cubated for 3 h at 37°C. Id2f/f- ERCre+/Id2f/f- ERCre− P14 
CD8+ T cells were mixed 1:1 and 106 cells were transferred 
into day −1 LCMV-infected hosts, and remaining cells were 
cultured in vitro with 50 U/ml human IL-2 for 4 d to assess 
for knockdown efficiency by qPCR. On day 15 of infection, 
tamoxifen was administered as described in the tamoxifen 
treatment section for 5 consecutive days to induce Id2 de-
letion. At 9 d after the last tamoxifen treatment, Id2WT and 
Id2KO populations were assessed by flow cytometry.
RNA-Seq, ChIP-Seq, and ATAC-Seq
6 d after the last tamoxifen treatment, 103 Id2WT and 
Id2KO P14 cells from recipients receiving mixed transfers of 
KLRG1hiCD127lo or KLRG1loCD127hi transfer were sorted 
into Buffer TCL (Qiagen) with 1% 2-mercaptoethanol. RNA 
was isolated, and libraries were prepared following Immgen 
protocols (https ://www .immgen .org /Protocols /11Cells 
.pdf). Libraries were analyzed on an Illumina HiSeq2500 
sequencer. Samples were generated from two biological 
replicates, and ∼10 million paired-reads were generated per 
sample. Reads were mapped by using Tophat, and aligned 
reads in transcripts were counted with HTseq. Analysis 
was performed by using the GenePattern Multiplot Studio 
module. TE and MP (Yu et al., 2017) and TEM and TCM gene 
signatures (Milner et al., 2017) represent genes that have a 
1.5-fold increased expression in that CD8+ T cell population. 
Principal component analysis used RNA-Seq data for TE and 
MP or TEM and TCM P14 CD8+ T cells from day 7 or 180 
after LCMV infection. E2A Bio-Chip analysis was deposited 
by Leong et al. (2016) (GEO accession code GSE84974), and 
ATAC-Seq data from Immgen (http ://rstats .immgen .org /
Chromatin /chromatin .html) was analyzed in the University 
of California, Santa Cruz, genome browser.
Statistics
The one- or two-tailed paired Student's t test was used for 
comparisons between groups as stated in the figure legends. 
The χ2 test was used to determine significant enrichment of 
gene sets in the RNA-Seq data. Statistical analysis was per-
formed by using GraphPad Prism software.
Online supplemental material
Fig. S1 shows analysis of CD8+ T cells responding to LCMV 
infection when Id2 deletion is induced in naive cells or at the 
peak of infection, as well as knockout efficiency when Id2 
deletion is induced >30 d after infection. Fig. S2 shows the 
mix of Id2WT and Id2KO CD8+ T cells for KLRG1hi and 
KLRG1lo transfers and additional phenotyping after LCMV 
rechallenge. This relates to Figs. 2 and 3. Fig. S3 shows Tcf3 
knockdown efficiency in Id2WT and Id2KO P14 CD8+ 
T cells transduced with retroviral shRNA constructs. Also, 
ATAC-Seq and E2A ChIP-Seq analysis of the Tcf7 loci for 
CD8+ T cell populations after LCMV infection is shown. 
This relates to Fig. 4.
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